Institute of Digestive Disease, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China.
J Gastroenterol Hepatol. 2011 Mar;26(3):432-6. doi: 10.1111/j.1440-1746.2010.06575.x.
There is an increasing burden in digestive cancer in the coming years. With the advancement of endoscopic therapy, new molecular target therapy and minimally invasive ablation therapy, the treatment of digestive cancer will become more complicated. In Asia where gastric cancer and hepatocellular carcinoma are still prevalent and colorectal cancer is rapidly on the rise, the need in digestive oncology will be even higher. A new subspecialty of digestive oncology will be needed from the patient's perspective, from the healthcare authority's viewpoint and for the future development of gastroenterology.
未来几年，消化系统癌症的负担将越来越重。随着内镜治疗、新的分子靶向治疗和微创消融治疗的进步，消化系统癌症的治疗将变得更加复杂。在胃癌和肝细胞癌仍然流行、结直肠癌迅速上升的亚洲，对消化系统肿瘤学的需求将更高。从患者的角度、从医疗保健当局的观点以及为了胃肠病学的未来发展，都需要一个新的消化系统肿瘤学亚专科。
